Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Sarepta Therapeutics (SRPT) Q1 2024 Earnings Call Transcript


Image source: The Motley Fool.

Sarepta Therapeutics (NASDAQ: SRPT)
Q1 2024 Earnings Call
May 01, 2024, 4:30 p.m. ET

Operator

Continue reading


Source Fool.com

Sarepta Therapeutics Stock

€143.50
-1.710%
A loss of -1.710% shows a downward development for Sarepta Therapeutics.
Sarepta Therapeutics is currently one of the favorites of our community with 8 Buy predictions and no Sell predictions.
With a target price of 187 € there is a positive potential of 30.31% for Sarepta Therapeutics compared to the current price of 143.5 €.
Like: 0
Share

Comments